TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein

Abstract Background The tripartite motif (TRIM) family of proteins plays a key role in the developmental growth and therapeutic resistance of many tumors. However, the regulatory mechanisms and biological functions of TRIM proteins in human glioblastoma (GBM) are not yet fully understood. In this st...

Full description

Bibliographic Details
Main Authors: Xu Yang, Yan Zhang, Zhiwei Xue, Yaotian Hu, Wenjing Zhou, Zhiyi Xue, Xuemeng Liu, Guowei Liu, Wenjie Li, Xiaofei Liu, Xingang Li, Mingzhi Han, Jian Wang
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:https://doi.org/10.1186/s13046-022-02534-8
_version_ 1811203662668627968
author Xu Yang
Yan Zhang
Zhiwei Xue
Yaotian Hu
Wenjing Zhou
Zhiyi Xue
Xuemeng Liu
Guowei Liu
Wenjie Li
Xiaofei Liu
Xingang Li
Mingzhi Han
Jian Wang
author_facet Xu Yang
Yan Zhang
Zhiwei Xue
Yaotian Hu
Wenjing Zhou
Zhiyi Xue
Xuemeng Liu
Guowei Liu
Wenjie Li
Xiaofei Liu
Xingang Li
Mingzhi Han
Jian Wang
author_sort Xu Yang
collection DOAJ
description Abstract Background The tripartite motif (TRIM) family of proteins plays a key role in the developmental growth and therapeutic resistance of many tumors. However, the regulatory mechanisms and biological functions of TRIM proteins in human glioblastoma (GBM) are not yet fully understood. In this study, we focused on TRIM56, which emerged as the most differentially expressed TRIM family member with increased expression in GBM. Methods Western blot, real-time quantitative PCR (qRT-PCR), immunofluorescence (IF) and immunohistochemistry (IHC) were used to study the expression levels of TRIM56 and cIAP1 in GBM cell lines. Co-immunoprecipitation (co-IP) was used to explore the specific binding between target proteins and TRIM56. A xenograft animal model was used to verify the tumor promoting effect of TRIM56 on glioma in vivo. Results We observed elevated expression of TRIM56 in malignant gliomas and revealed that TRIM56 promoted glioma progression in vitro and in a GBM xenograft model in nude mice. Analysis of the Human Ubiquitin Array and co-IPs showed that cIAP1 is a protein downstream of TRIM56. TRIM56 deubiquitinated cIAP1, mainly through the zinc finger domain (amino acids 21–205) of TRIM56, thereby reducing the degradation of cIAP1 and thus increasing its expression. TRIM56 also showed prognostic significance in overall survival of glioma patients. Conclusions TRIM56-regulated post-translational modifications may contribute to glioma development through stabilization of cIAP1. Furthermore, TRIM56 may serve as a novel prognostic indicator and therapeutic molecular target for GBM.
first_indexed 2024-04-12T03:00:11Z
format Article
id doaj.art-fd8b62aabe874c32987cbe945dbb348b
institution Directory Open Access Journal
issn 1756-9966
language English
last_indexed 2024-04-12T03:00:11Z
publishDate 2022-12-01
publisher BMC
record_format Article
series Journal of Experimental & Clinical Cancer Research
spelling doaj.art-fd8b62aabe874c32987cbe945dbb348b2022-12-22T03:50:42ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662022-12-0141111810.1186/s13046-022-02534-8TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 proteinXu Yang0Yan Zhang1Zhiwei Xue2Yaotian Hu3Wenjing Zhou4Zhiyi Xue5Xuemeng Liu6Guowei Liu7Wenjie Li8Xiaofei Liu9Xingang Li10Mingzhi Han11Jian Wang12Department of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong UniversityDepartment of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong UniversityDepartment of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong UniversityDepartment of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong UniversityDepartment of Blood Transfusion, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong UniversityDepartment of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong UniversityDepartment of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong UniversityDepartment of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong UniversityDepartment of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong UniversityDepartment of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong UniversityDepartment of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong UniversityDepartment of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong UniversityAbstract Background The tripartite motif (TRIM) family of proteins plays a key role in the developmental growth and therapeutic resistance of many tumors. However, the regulatory mechanisms and biological functions of TRIM proteins in human glioblastoma (GBM) are not yet fully understood. In this study, we focused on TRIM56, which emerged as the most differentially expressed TRIM family member with increased expression in GBM. Methods Western blot, real-time quantitative PCR (qRT-PCR), immunofluorescence (IF) and immunohistochemistry (IHC) were used to study the expression levels of TRIM56 and cIAP1 in GBM cell lines. Co-immunoprecipitation (co-IP) was used to explore the specific binding between target proteins and TRIM56. A xenograft animal model was used to verify the tumor promoting effect of TRIM56 on glioma in vivo. Results We observed elevated expression of TRIM56 in malignant gliomas and revealed that TRIM56 promoted glioma progression in vitro and in a GBM xenograft model in nude mice. Analysis of the Human Ubiquitin Array and co-IPs showed that cIAP1 is a protein downstream of TRIM56. TRIM56 deubiquitinated cIAP1, mainly through the zinc finger domain (amino acids 21–205) of TRIM56, thereby reducing the degradation of cIAP1 and thus increasing its expression. TRIM56 also showed prognostic significance in overall survival of glioma patients. Conclusions TRIM56-regulated post-translational modifications may contribute to glioma development through stabilization of cIAP1. Furthermore, TRIM56 may serve as a novel prognostic indicator and therapeutic molecular target for GBM.https://doi.org/10.1186/s13046-022-02534-8GliomaDeubiquitylationTRIM56cIAP1
spellingShingle Xu Yang
Yan Zhang
Zhiwei Xue
Yaotian Hu
Wenjing Zhou
Zhiyi Xue
Xuemeng Liu
Guowei Liu
Wenjie Li
Xiaofei Liu
Xingang Li
Mingzhi Han
Jian Wang
TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein
Journal of Experimental & Clinical Cancer Research
Glioma
Deubiquitylation
TRIM56
cIAP1
title TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein
title_full TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein
title_fullStr TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein
title_full_unstemmed TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein
title_short TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein
title_sort trim56 promotes malignant progression of glioblastoma by stabilizing ciap1 protein
topic Glioma
Deubiquitylation
TRIM56
cIAP1
url https://doi.org/10.1186/s13046-022-02534-8
work_keys_str_mv AT xuyang trim56promotesmalignantprogressionofglioblastomabystabilizingciap1protein
AT yanzhang trim56promotesmalignantprogressionofglioblastomabystabilizingciap1protein
AT zhiweixue trim56promotesmalignantprogressionofglioblastomabystabilizingciap1protein
AT yaotianhu trim56promotesmalignantprogressionofglioblastomabystabilizingciap1protein
AT wenjingzhou trim56promotesmalignantprogressionofglioblastomabystabilizingciap1protein
AT zhiyixue trim56promotesmalignantprogressionofglioblastomabystabilizingciap1protein
AT xuemengliu trim56promotesmalignantprogressionofglioblastomabystabilizingciap1protein
AT guoweiliu trim56promotesmalignantprogressionofglioblastomabystabilizingciap1protein
AT wenjieli trim56promotesmalignantprogressionofglioblastomabystabilizingciap1protein
AT xiaofeiliu trim56promotesmalignantprogressionofglioblastomabystabilizingciap1protein
AT xingangli trim56promotesmalignantprogressionofglioblastomabystabilizingciap1protein
AT mingzhihan trim56promotesmalignantprogressionofglioblastomabystabilizingciap1protein
AT jianwang trim56promotesmalignantprogressionofglioblastomabystabilizingciap1protein